Publications by authors named "N Houede"

Claim this Profile
A
ALBAN (GETUG-AFU 37): a phase III, randomized, open-label international trial of intravenous atezolizumab and intravesical Bacillus Calmette-Guérin (BCG) versus BCG alone in BCG-naive high-risk, non-muscle-invasive bladder cancer (NMIBC).
M Roupret, A Bertaut, G Pignot, Y Neuzillet, N Houede

Ann Oncol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic polymorphisms of and genes are associated with exposure to sunitinib and cardiovascular toxicity.
Litaty C Mbatchi, Fanny Leenhardt, Bob-Valéry Occean, Olivier Perrin, Jean-Christophe Boyer, Nadine Houede

Pharmacogenomics· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of FGFR3 Alterations on First-Line Platinum Based Chemotherapy in Patients With Metastatic or Locally Advanced Urothelial Carcinoma: The Retrospective IFUCA Study.
Thibaut Reverdy, Floriane Izarn, Benoit Allignet, Guilhem Roubaud, Nyere Gibson, Nadine Houede

Clin Genitourin Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A feasibility study of scheduling a remission consultation in the management of patients treated for localized breast cancer.
Sandrine Alonso, Sarah Kabani, Pascale Fabbro-Peray, Nadine Houédé, Luc Duwig

BMC Psychol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient Versus Clinician Reported Symptoms Agreement in Advanced Metastatic Bladder Cancer Patients.
Soufyan Annakib, Emma Di Méglio, Yona Dibert-Bekoy, Thierry Chevallier, Guilhem Roubaud

Cancer Med· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis